Ipilimumab and Nivolumab induced ventricular tachycardia in a patient with metastatic renal cell carcinoma
The immune checkpoint inhibitor (ICIs) as Nivolumab and Ipilimumab is a novel class of medication used in the management of several metastatic malignancies. ICIs can cause immune-related adverse events due to autoreactive T cell activation. Cardiovascular complications comprised myocarditis, conduct...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Taylor & Francis Group
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/f001346cc9f9404f9dc06899395f630d |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|